Vitamin c in anemia

Investigating the effect of iron supplementation with and without vitamin c on iron deficiency anemia, iron and hematologic Indices of patients reffered to touba clinic

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241127063874N1

Enrollment

Registered

2025-06-27

Start date

2025-06-22

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia. Iron deficiency anemia

Interventions

Intervention 1: During this study, Ferrofort Duodenal tablets produced by the pharmaceutical company (Abidi, Ferrous Glycine Sulphate: 80 mg) will be prescribed to patients in two intervention groups.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Iron deficiency anemia and willingness to participate in the study and follow-up

Exclusion criteria

Exclusion criteria: Receiving iron or blood supplements within the past two months, acute infection, severe liver failure, gastrointestinal bleeding, taking multivitamins or vitamin C supplements within the past two months

Design outcomes

Primary

Measure	Time frame
Changes in Hb anf Ferritin and Fe. Timepoint: 2 months after intervention. Method of measurement: Biochemical and ELISA methods.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Ehsani

Mazandaran University of Medical Sciences

Zehsani@mazums.ac.ir+98 911 177 0256

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026